[TOP STORY] The appetite for GLP-1 drugs grows

Loading player...
‘The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, Integral Asset Management’s Keith McLachlan points out.
24 Jan 3AM English South Africa Business News · Business

Other recent episodes

Sasol strength points to continued growth

Herenya Capital Advisors’s Petri Redelinghuys: Is he still short the Top40 and still long on Sasol? Sanlam Credit Partnerships CEO Alet Griesel looks at good vs bad debt, and how women are leveraging credit to change their lives. DebtBusters’s Benay Sager discusses how the share of income going to debt…
21 Aug 1AM 21 min

BHP Group upbeat despite earnings slip

Chantal Marx, FNB Wealth & Investments, on BHP Group’s results as the market brushed off profits falling to a five-year low. Scott Cummins, Aveng CEO, on results as two challenging projects pushed the company into a loss for the period. Bradd Bendall, BetterBond, on a strong July in the home…
20 Aug 1AM 20 min